Form 4 for ABT Abbott Laboratories
Accepted 2026-09-03 18:02:03 ET · period of report 2026-09-01 · accession 0001805099-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 18:02 | 2026-09-01 | ABT | Boudreau Philip P | EVP AND CFO | F - Tax | $110.36 | -388 | 70.8K | -0.5% | -$42.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-09-01 | F | D | 388 | $110.36 | 70,784 | D | — | — |